Hormones, drugs, remodeling and outcome in heart failure and after myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 15, Issue 1, 2001, Pages 9-10

  Cohn, J N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

EDITORIAL; GOOD CLINICAL PRACTICE; HEART FAILURE; HEART INFARCTION; LIFE EXPECTANCY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; HEART FAILURE, CONGESTIVE; HORMONES; HUMANS; MYOCARDIAL INFARCTION; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 0034927104     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011146415175     Document Type: Editorial

References (11)

1. Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
2. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
3. The effect of captopril on mortality and morbidity in patients with left ventricular dysfunction following myocardial infarction: Results of the survival and ventricular enlargement (SAVE) trial
4. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
6. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
7. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
8. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
9. Rationale and design of the Valsartan Heart Failure Trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure
10. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
11. The Carvedilol and ACE inhibitor Remodelling Mild heart failure Evaluation Trial (CARMEN) - Rationale and design